Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Desmosterolosis is a very rare sterol biosynthesis disorder characterized by multiple congenital anomalies, failure to thrive, and intellectual disability, with elevated levels of desmosterol.
Features include always present findings: Elevated circulating desmosterol concentration, Short stature, Abnormal cholesterol levels (abnormal circulating cholesterol concentration), and Global developmental delay and others; and very common findings: Failure to thrive, Enlarged brain ventricles (ventriculomegaly), Distal arthrogryposis, and Reduced cerebral white matter volume and others. 48 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 |
DHCR24 encodes 24-dehydrocholesterol reductase (516 aa). Catalyzes the reduction of the delta-24 double bond of sterol intermediates during cholesterol biosynthesis. Highest expression in Adrenal Gland (1,544 TPM) and Brain Spinal cord cervical c-1 (624.1 TPM).
Desmosterolosis is caused by mutations in the DHCR24 gene on chromosome 1.
The DHCR24 protein participates in Cholesterol biosynthesis from zymosterol (modified Kandutsch-Russell pathway) pathway.
DHCR24 is classified as a druggable target (Enzyme category) with score 6.5.
Genetic testing for DHCR24 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 7 always present features, 5 very common features, 20 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
5 publications have been identified in PubMed for desmosterolosis. Research spans Review / Meta-Analysis (40%), Basic Science / Preclinical (40%), and Case Report / Case Series (20%).
Kose CC (2026). [PMID: 41500862](https://pubmed.ncbi.nlm.nih.gov/41500862/). *Journal of clinical lipidology*. [Case Report / Case Series]
Zhu H (2026). [PMID: 41987278](https://pubmed.ncbi.nlm.nih.gov/41987278/). *Lipids Health Dis*. [Review / Meta-Analysis]
Westbye AB (2025). [PMID: 39566847](https://pubmed.ncbi.nlm.nih.gov/39566847/). *J Lipid Res*. [Review / Meta-Analysis]
Wang X (2024). [PMID: 38775844](https://pubmed.ncbi.nlm.nih.gov/38775844/). *Cellular and molecular life sciences : CMLS*. [Basic Science / Preclinical]
Hegde PS (2024). [PMID: 39606856](https://pubmed.ncbi.nlm.nih.gov/39606856/). *J Dev Orig Health Dis*. [Basic Science / Preclinical]
Data assembled from 8 of 12 sources · Last updated Sep 18, 2026, 1:23 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Seizure, Hydrocephalus, Global developmental delay
Head and neck | 4 | Relative macrocephaly, Cleft palate, Microcephaly |
Bones and joints | 3 | Increased bone density (increased bone mineral density), Generalized osteosclerosis, Joint contracture of the hand |
Muscles | 3 | Distal arthrogryposis, Joint contracture of the hand, Joint stiffness present at birth (arthrogryposis multiplex congenita) |
Eyes | 2 | Strabismus, Nystagmus |
Growth and development | 2 | Short stature, Failure to thrive |
Lab test results | 1 | Elevated circulating desmosterol concentration |
Digestive system | 1 | Abnormal cholesterol levels (abnormal circulating cholesterol concentration) |
Lungs and breathing | 1 | Total anomalous pulmonary venous return |
Arms and legs | 1 | Joint contracture of the hand |
Age of onset: at birth.